Janney Montgomery Scott
VCYT icon

Janney Montgomery Scott’s Veracyte VCYT Stock Holding History

Janney Montgomery Scott’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,100
Closed -$72K – 2013
2017
Q4 		$72K Buy
+11,100
New +$82.5K ﹤0.01% 1894

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Janney Montgomery Scott's VCYT Position: Q1 2018 in Review

Janney Montgomery Scott sold out of Veracyte (VCYT) in Q1 2018, closing a stake of 11,100 shares — an estimated $72K sold.

Janney Montgomery Scott first reported a position in VCYT in Q4 2017 and held it in 1 quarter. The position peaked at $72K in Q4 2017. 80 funds tracked by Wall St. Rank hold VCYT as of Q1 2018.

  • Janney Montgomery Scott reported no remaining Veracyte position as of Q1 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 11,100 Veracyte shares in Q1 2018, an estimated $72K.
  • Janney Montgomery Scott first reported a position in Veracyte in Q4 2017 and held it in 1 quarter.
  • Janney Montgomery Scott's Veracyte position peaked at $72K in Q4 2017.
  • 80 funds tracked by Wall St. Rank held Veracyte as of Q1 2018.

Based on Janney Montgomery Scott's 13F filing for Q1 2018, filed 19 Apr 2018.